Article
The clinical introduction of genetic testing for Alzheimer disease. An ethical perspective.
JAMA - 12 Mar 1997
Post S G, Whitehouse P J, Binstock R H, Bird T D, Eckert S K, Farrer L A, Fleck L M, Gaines A D, Juengst E T, Karlinsky H, Miles S, Murray T H, Quaid K A, Relkin N R, Roses A D, St George-Hyslop P H, Sachs G A, Steinbock B, Truschke E F, Zinn A B
Abstract excerpt
OBJECTIVE: Primary caregivers should be aware of recent progress in the genetics of Alzheimer disease (AD) and of the clinical and ethical considerations raised regarding the introduction of genetic testing for purposes of disease prediction and susceptibility (risk) analysis in asymptomatic indi...
Topics
- Advisory Committees
- Alleles
- Alzheimer Disease
- Apolipoproteins E
- Chromosomes, Human, Pair 1
- Chromosomes, Human, Pair 14
- Chromosomes, Human, Pair 21
- Consensus
- Ethics, Medical
- Genetic Testing
- Humans
- Mutation
- Predictive Value of Tests